Jean‐Michel Heard
- Virology top 0.2%
- HIV Research and Treatment 13
- Immunology top 1%
- Immunotherapy and Immune Responses 5
- Oncology top 5%
- Infectious Diseases top 2%
- Genetics top 2%
- Virus-based gene therapy research 14
-
- Lysosomal Storage Disorders Research 11
-
- Cellular transport and secretion 6
-
- RNA Interference and Gene Delivery 5
- CRISPR and Genetic Engineering 5
-
- Trypanosoma species research and implications 5
- Co-authors
- Olivier SchwartzOlivier DanosFernando Arenzana‐SeisdedosValérie MaréchalJean‐Louis VirelizierAli AmaraMarco BaggioliniIan Clark‐Lewis
- Cited by
- VirologyImmunologyOncology
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Jean‐Michel Heard
51 papers receiving 4.4k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Virology 1.8k
- Immunology 1.9k
- Oncology 918
- Infectious Diseases 585
- Genetics 772
Countries citing papers authored by Jean‐Michel Heard
This map shows the geographic impact of Jean‐Michel Heard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Michel Heard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Michel Heard more than expected).
Fields of papers citing papers by Jean‐Michel Heard
This network shows the impact of papers produced by Jean‐Michel Heard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Michel Heard. The network helps show where Jean‐Michel Heard may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jean‐Michel Heard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 1 | |
| 2 | 2021 | 21 | |
| 3 | 2021 | 29 | |
| 4 | 2019 | 3 | |
| 5 | 2017 | 151 | |
| 6 | 2010 | 128 | |
| 7 | 2010 | 8 | |
| 8 | 2009 | 9 | |
| 9 | 2008 | 1 | |
| 10 | 2006 | 20 | |
| 11 | 2002 | 160 | |
| 12 | 2000 | 3 | |
| 13 | 1998 | 7 | |
| 14 | 1997 | 40 | |
| 15 | 1997 | 40 | |
| 16 | The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1breakdown → | 1996 | 1425 |
| 17 | 1995 | 14 | |
| 18 | 1994 | 71 | |
| 19 | 1993 | 146 | |
| 20 | 1987 | 152 |
About Jean‐Michel Heard
Jean‐Michel Heard is a scholar working on Virology, Genetics and Physiology, having authored 52 papers that have together received 4.5k indexed citations. Recurring topics across this work include Virus-based gene therapy research (14 papers), HIV Research and Treatment (13 papers), Lysosomal Storage Disorders Research (11 papers), Cellular transport and secretion (6 papers), RNA Interference and Gene Delivery (5 papers), CRISPR and Genetic Engineering (5 papers), Immunotherapy and Immune Responses (5 papers) and Trypanosoma species research and implications (5 papers). The work is most often cited by research in Virology (1.8k citations), Immunology (1.9k citations) and Oncology (918 citations). Jean‐Michel Heard has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Olivier Schwartz, Olivier Danos, Fernando Arenzana‐Seisdedos, Valérie Maréchal, Jean‐Louis Virelizier, Ali Amara, Marco Baggiolini, Ian Clark‐Lewis, Daniel F. Legler and Bernhard Moser. Their work appears in journals such as Journal of Virology, Human Gene Therapy, Virology, Molecular Genetics and Metabolism and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.